Mylan Makes Offer to Buy Swedish Drugmaker Meda for 92% Premium
They are so determined to make themselves too big to acquire that the will overpay for acquisitions. The irony is that the TEVA offer was almost 90% above where MYL is trading now. Management has no respect or concern for shareholders, and will pretty much #$%$ all over them. That is why the stock is down.
How is it that out of 7 analysts, the low price target is $25? Does anyone ever update this info? What is the time frame for these price targets? Or are analysts and Yahoo conspiring to put out misinformation? This month, 3 of the analysts had CARA a strong buy... the other 4 had CARA a buy... SUPPOSEDLY
Mean Recommendation (this week): 1.6
Mean Recommendation (last week): 1.6
* (Strong Buy) 1.0 - 5.0 (Sell)
Price Target Summary
Mean Target: 28.86
High Target: 34.00
Low Target: 25.00
No. of Brokers: 7
Data provided by Thomson/First Call
Upgrades & Downgrades History
Date Research Firm Action From To
Nov 4, 2015 Cantor Fitzgerald Initiated Buy
Mar 3, 2015 MLV & Co Initiated Buy
Jan 9, 2015 Canaccord Genuity Initiated Buy
Dec 9, 2014 Summer Street Research Initiated Buy
Feb 27, 2014 Needham Initiated Buy
Feb 25, 2014 Stifel Initiated Buy
Feb 25, 2014 Canaccord Genuity Initiated Buy
Huge volume! Have done almost a fill days volume in less than 2 hours. 4.5+ still to go. And this stock has limited float. Is CARA done? Or getting ready to explode up? They raised a lot of money last year, so no reason to dilute at these prices. I am adding... feel like biotechs have fallen out of favor, but the valuations are getting silly.
Hey folks... let's face it, either management is totally incompetent or we got conned (i lean towards incompetence, with over-optimism leading to some misrepresentation). I appreciate everyone who invested and wants to be optimistic, but it will take a miracle for this company/stock to recover. At this point, I suspect management is just milking this for all it is worth. Might as well take the paycheck as long as possible -- while there is life, there is hope... but I can't see even a glimmer of anything positive... and management is being pretty tight lipped. The patient is on life support, and even V-Bloc can't save them. Let me know if you think I'm wrong. P.S. I'm holding 'cause it's not worth selling.
MS is a con artist who manipulates the system in an unethical - but perhaps legal - manner. Personally, I bet he is selling off shares hand over fist on the upticks to lock in a huge profit. He stands to walk away with maybe 50+ million on a
Sentiment: Strong Sell
Maybe SWKS should just walk away.... they stand to get 88.5 million break-up fee if the MicroSemi deal wins out... or they have to pony up another 40 million to raise their offer to compete for PMCS deal. Starts to get pricey. 88.5 million is a nice consolation prize.
GoPro is a $19 stock today and perhaps going much lower. The shares have dropped 6+ percent today courtesy of Piper Jaffray lowering their price target for the stock to $15. Of course, this is the same Piper Jaffray that one year ago was pumping this stock to the moon (September 29, 2014 10:58 AM. Piper Jaffray maintained an Overweight rating on GoPro (NASDAQ: GPRO) and raised its price target to $90.00 (from $60.00).) I don't think that a lot has changed in the GoPro story. They are still growing, though not as fast... though their earlier rate of growth was unsustainable. The problem is that analysts and investment advisors are not held to any professional criteria. They have no fiduciary obligation to clients, or those who read their reports in publications. Just look at the financial collapse of 2008-9. No one was held accountable for the excessive risks and countless frauds which were perpetrated. The markets today are driven by analysts, traders, and machines, making valuations increasingly suspect. Still with interest rates historically low, the stock market is really the only game in town... be careful, and good luck to all.
For the record, I bought SKUL at $13 years ago, and sold when it rallied into the 9s last year. I still follow it, but have not bought back in. The problem is that MOST of their products are in a market segment that is largely commoditized. SKUL is not the strongest brand, does not have a lot of market share, and does not appear to have the resources to compete on technology. I like the domestic/Utah story, and the management "connection" to Nike, but I also have (anecdotally) seen their brand lose appeal for young people, and seen them disappear from/or get reduced skus from stores in my local market/Atlanta. So to me, this is still a high risk stock... good potential upside, but downside to zero. Their sales have still not recovered to the levels where they were several years ago. The business appears to have stabilized, but growth is hard to come by, and they have no moat around their business that I can see. Still I'd love to see them succeed... you just have to do your due diligence and take the cheer leading of the bulls on this board with a grain of salt. Nothing wrong with rooting for the home team, but it doesn't mean they are going to win. Good luck to all.
Took NUAN's surge over $20 as an opportunity to get out. I love the technology, but don't like the management, and have been disappointed too many times. In fairness, my selling is probably a buy signal, but I feel my money is better off deployed elsewhere after years of underperformance. Don't understand why another company would buy out NUAN now, when they could have had it a lot cheaper over the past couple of years. I'll keep watching and maybe get back in if it pulls back. Would love to hear thoughts on why prospects have materially changed, especially as competition in the speech recognition area seems to be growing. Good luck to all.